DNAJC5, also known as Cysteine String Protein (CSP) or Csp1, is a member of the DnaJ/Hsp40 co-chaperone family encoded by the DNAJC5 gene on chromosome 20q13.33. Originally identified as a synaptic vesicle protein with a unique cysteine-rich "string" motif, DNAJC5 plays essential roles in protein folding, synaptic transmission, and neuronal survival. Dominant mutations in DNAJC5 cause adult-onset neuronal ceroid lipofuscinosis (ANCL), and the gene has been implicated in both Alzheimer's and Parkinson's disease.
¶ Gene Structure and Expression
The DNAJC5 gene spans approximately 12.5 kb and contains 7 exons. It encodes a protein of 292 amino acids with a molecular weight of approximately 34 kDa.
Domain architecture:
- N-terminal J domain: ~70 aa, HPD motif for Hsp70 interaction
- Cysteine-rich string region: ~30 cysteines with palmitoylation sites (membrane association)
- C-terminal substrate-binding region: Client protein recognition
Expression pattern:
- Primary: Neurons throughout the CNS and PNS
- Highest expression: Hippocampus (CA1-3, dentate gyrus), cerebral cortex, cerebellum (Purkinje cells)
- Cellular localization: Presynaptic terminals, synaptic vesicles, endoplasmic reticulum
DNAJC5 functions as a co-chaperone for Hsp70 family proteins:
- J domain proteins: Recruit and stimulate Hsp70 ATPase activity
- Substrate delivery: Bind unfolded/misfolded proteins for Hsp70-mediated refolding
- Hsp70 partners: Predominantly interacts with Hsc70 (HSPA8) in neurons
The cysteine string domain is critical for:
- Synaptic vesicle anchoring: Palmitoylation targets DNAJC5 to vesicle membranes
- Vesicle cycling: Essential for synaptic vesicle endocytosis and recycling
- SNARE complex assembly: Facilitates formation of the SNARE machinery
- Calcium sensing: Regulates exocytosis through interaction with synaptotagmin
DNAJC5 participates in neuronal proteostasis:
- Chaperone-mediated protein folding: Prevents aggregation of client proteins
- ER-associated degradation (ERAD): Coordinates with Hsp70 for misfolded protein clearance
- Autophagy regulation: Directs damaged proteins to autophagic pathways
Dominant DNAJC5 mutations cause ANCL, a lysosomal storage disorder:
- Mutation types: Missense mutations in the J domain (p.G117V, p.L175P)
- Pathogenesis: Impaired chaperone function leads to accumulation of lipofuscin
- Clinical features: Progressive neurodegeneration, dementia, seizures, ataxia
- Inheritance: Autosomal dominant with incomplete penetrance
DNAJC5 is implicated in AD through several mechanisms:
- APP processing: Hsc70-DNAJC5 complexes regulate APP trafficking through the secretory pathway
- Aβ generation: Altered DNAJC5 function affects amyloidogenic processing
- Synaptic dysfunction: Loss of DNAJC5 impairs synaptic vesicle cycling
- Protein aggregation: Impaired chaperone function may contribute to tau and Aβ pathology
- α-Synuclein interaction: DNAJC5 can modulate α-synuclein aggregation and clearance
- LRRK2 pathway: DNAJC5 expression is altered in LRRK2-associated PD
- Mitochondrial quality control: DNAJC5 contributes to mitochondrial protein folding
- Neuroprotection: DNAJC5 overexpression protects against PD-relevant toxins
- Huntington's disease: DNAJC5 dysfunction contributes to mutant huntingtin toxicity
- Amyotrophic lateral sclerosis: Altered expression in motor neurons
- Spinocerebellar ataxias: Interacts with ataxin proteins
| Disease |
Inheritance |
Mutation Type |
Clinical Features |
| ANCL |
Autosomal dominant |
Missense (J domain) |
Dementia, seizures, ataxia |
| Epilepsy |
De novo |
Missense |
Early-onset seizures |
DNAJC5 represents a potential therapeutic target:
- Chaperone enhancers: Small molecules that restore DNAJC5 function
- Gene therapy: Viral vector delivery to increase expression
- Protein replacement: Not applicable (protein not secreted)
- Symptomatic approaches: Targeting downstream synaptic dysfunction
Challenges:
- Dominant negative mechanism in ANCL complicates therapeutic approaches
- Blood-brain barrier limits CNS delivery
- Balancing chaperone activity without disrupting normal function
| Protein |
Interaction Type |
Functional Significance |
| Hsc70 (HSPA8) |
J domain binding |
Chaperone activity |
| Hsp40 (DNAJB1) |
Co-chaperone network |
Client protein handling |
| Synaptobrevin-2 |
Indirect (SNARE) |
Exocytosis |
| Synaptotagmin-1 |
Indirect |
Calcium sensing |
| α-Synuclein |
Client protein |
Aggregation modulation |
| APP |
Indirect (trafficking) |
Amyloid processing |